Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Sykes Enterprises	Unisys	Telos	NetScout Systems	Simulations Plus
Symbol	NASDAQ:SYKE	NYSE:UIS	NASDAQ:TLS	NASDAQ:NTCT	NASDAQ:SLP
Price Information
Current Price	$44.06	$24.13	$34.40	$27.80	$62.50
52 Week Range	Buy	Buy	Buy	Hold	Buy
MarketRank™
Overall Score	1.4	1.0	1.7	1.2	2.0
Analysis Score	1.5	0.0	3.5	1.0	3.4
Community Score	2.0	2.3	4.6	2.6	2.4
Dividend Score	0.0	0.0	0.0	0.0	1.7
Ownership Score	1.7	1.7	0.0	1.7	0.8
Earnings & Valuation Score	1.9	1.3	0.6	0.6	1.9
Analyst Ratings
Consensus Recommendation	Buy	Buy	Buy	Hold	Buy
Consensus Price Target	$44.00	N/A	$41.86	$24.67	$84.25
% Upside from Price Target	-0.14% downside	N/A	21.68% upside	-11.27% downside	34.80% upside
Trade Information
Market Cap	$1.75 billion	$1.62 billion	$2.22 billion	$2.04 billion	$1.25 billion
Beta	0.89	0.54	N/A	1.07	-0.07
Average Volume	150,690	561,563	826,975	424,838	209,918
Sales & Book Value
Annual Revenue	$1.61 billion	$2.95 billion	N/A	$891.82 million	$41.59 million
Price / Sales	1.08	0.55	N/A	2.29	30.00
Cashflow	$4.01 per share	$5.17 per share	N/A	$2.49 per share	$0.65 per share
Price / Cash	11.00	4.67	N/A	11.18	95.51
Book Value	$21.10 per share	($19.69) per share	N/A	$26.24 per share	$7.92 per share
Price / Book	2.09	-1.23	N/A	1.06	7.89
Profitability
Net Income	$64.08 million	$-17,200,000.00	N/A	$-2,750,000.00	$9.33 million
EPS	$2.11	N/A	N/A	$1.00	$0.56
Trailing P/E Ratio	33.38	1.65	0.00	92.67	122.55
Forward P/E Ratio	14.99	∞	122.86	25.27	91.91
P/E Growth	1.42	N/A	N/A	5.63	8.45
Net Margins	3.21%	41.67%	N/A	2.61%	22.74%
Return on Equity (ROE)	12.31%	-14.56%	N/A	4.77%	10.65%
Return on Assets (ROA)	7.72%	2.66%	N/A	2.99%	9.51%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	$0.24
Dividend Yield	N/A	N/A	N/A	N/A	0.38%
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	14.29%
Payout Ratio	N/A	N/A	N/A	N/A	42.86%
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	1 Years
Debt
Debt-to-Equity Ratio	0.01%	N/A	N/A	0.23%	N/A
Current Ratio	1.97%	1.73%	N/A	1.85%	23.96%
Quick Ratio	1.97%	1.71%	N/A	1.78%	23.45%
Ownership Information
Institutional Ownership Percentage	88.73%	98.65%	N/A	94.67%	60.75%
Insider Ownership Percentage	4.40%	2.30%	N/A	4.36%	24.45%
Miscellaneous
Employees	54,900	17,200	785	2,502	129
Shares Outstanding	39.61 million	66.98 million	64.63 million	73.44 million	19.97 million
Next Earnings Date	5/3/2021 (Estimated)	5/6/2021 (Confirmed)	6/24/2021 (Estimated)	5/6/2021 (Estimated)	4/12/2021 (Confirmed)
Optionable	Optionable	Optionable	Not Optionable	Optionable	Optionable

Source	Headline
	Simulations Plus's Earnings: A Preview benzinga.com - April 9 at 2:45 PM
	Simulations Plus, Inc.'s (NASDAQ:SLP) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? finance.yahoo.com - April 8 at 1:18 PM
	Simulations Plus Stock Is Estimated To Be Significantly Overvalued finance.yahoo.com - April 8 at 12:19 AM
	Simulations Plus (SLP) to Post Q2 Earnings: What to Expect? finance.yahoo.com - April 7 at 2:05 PM
	Simulations Plus Reports Successful Results from AIDD Collaboration with Large Pharmaceutical Company finance.yahoo.com - April 7 at 9:04 AM
	Simulations Plus (NASDAQ:SLP) Shares Gap Up to $63.03 americanbankingnews.com - April 6 at 11:02 AM
	Zacks: Brokerages Anticipate Simulations Plus, Inc. (NASDAQ:SLP) Will Post Earnings of $0.14 Per Share americanbankingnews.com - April 3 at 10:10 AM
	Should You Consider Simulations Plus (SLP) as Good Investment? finance.yahoo.com - April 2 at 7:47 AM
	Simulations Plus Sets Date for Second Quarter Fiscal Year 2021 Earnings Release and Conference Call finance.yahoo.com - March 29 at 4:53 PM
	Simulations Plus Forms Scientific Advisory Board for RENAsym Consortium finance.yahoo.com - March 16 at 12:52 PM
	Simulations Plus Hosts the Inaugural 2021 MIDD+ Scientific Conference with over 50 Model-Informed Drug Development Sessions finance.yahoo.com - March 11 at 10:12 AM
	Simulations Plus to Present at Oppenheimer Healthcare Conference finance.yahoo.com - March 9 at 9:43 AM
	Notable Two Hundred Day Moving Average Cross - SLP nasdaq.com - March 4 at 3:54 PM
	Simulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety Collaboration finance.yahoo.com - February 23 at 12:44 PM
	What We Learned About Simulations Plus' (NASDAQ:SLP) CEO Pay finance.yahoo.com - February 22 at 3:23 PM
	Simulations Plus to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference finance.yahoo.com - February 11 at 2:24 PM
	Simulations Plus Releases GastroPlus® Version 9.8.1 finance.yahoo.com - February 9 at 9:02 AM
	Simulations Plus Enters Agreement with Distributor in China finance.yahoo.com - February 2 at 1:16 PM
	Simulations Plus Expands Marketing and Sales Operations in South America Through Partnership with the Institute of Pharmaceutical Sciences finance.yahoo.com - January 26 at 1:31 PM
	Teladoc Reaches 80-Plus Relative Strength Rating Benchmark finance.yahoo.com - January 26 at 1:31 PM
	NASDAQ:SLP Investor Alert: Investigation over Potential Wrongdoing at Simulations Plus, Inc. sbwire.com - January 25 at 2:15 PM
	Investigation announced for Investors in NASDAQ: SLP shares over potential Securities Laws Violations by Simulations Plus, Inc. openpr.com - January 21 at 7:09 PM
	Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics finance.yahoo.com - January 14 at 7:14 PM
	Simulations Plus (SLP) Stock Down Despite Q1 Earnings Beat nasdaq.com - January 13 at 2:03 PM
	Simulations Plus Enters New Funded Collaboration to Improve Lung Exposure Models for Pulmonary Infection Treatments finance.yahoo.com - January 12 at 3:14 PM

Date	Company	Brokerage	Action
2/25/2021	Sykes Enterprises	Barrington Research	Boost Price Target
6/4/2020	Sykes Enterprises	Robert W. Baird	Upgrade
3/16/2020	Sykes Enterprises	Sidoti	Upgrade
4/12/2019	Sykes Enterprises	SunTrust Banks	Downgrade
2/10/2020	Unisys	Canaccord Genuity	Reiterated Rating
12/12/2018	Unisys	Loop Capital	Set Price Target
4/1/2021	Telos	Needham & Company LLC	Boost Price Target
4/1/2021	Telos	Wedbush	Boost Price Target
3/26/2021	Telos	Northland Securities	Boost Price Target
3/26/2021	Telos	DA Davidson	Boost Price Target
3/26/2021	Telos	B. Riley	Boost Price Target
3/26/2021	Telos	BMO Capital Markets	Boost Price Target
12/14/2020	Telos	Colliers Securities	Initiated Coverage
10/29/2020	NetScout Systems	Lake Street Capital	Downgrade
10/29/2020	NetScout Systems	Piper Sandler	Upgrade
5/8/2020	NetScout Systems	Royal Bank of Canada	Boost Price Target
10/11/2019	NetScout Systems	Piper Jaffray Companies	Downgrade
11/1/2018	NetScout Systems	Craig Hallum	Set Price Target
1/12/2021	Simulations Plus	Oppenheimer	Boost Price Target
11/25/2020	Simulations Plus	Taglich Brothers	Upgrade
10/16/2020	Simulations Plus	Raymond James	Initiated Coverage

(Data available from 4/11/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources